Search / Trial NCT06614634

Comparison of Conventional and Tele-cardiac Rehabilitation

Launched by GAZI UNIVERSITY · Sep 24, 2024

Trial Information

Current as of December 22, 2024

Completed

Keywords

Cardiac Rehabilitation Telerehabilitation Coronary Artery Disease Tele Cardiac Rehabilitation Fear Of Activity

ClinConnect Summary

This prospective, patient-preference, controlled study aimed to investigate the comparative effects of tele-cardiac rehabilitation (TCR) and hospital-based cardiac rehabilitation (HBCR) on functional capacity, fear of activity, and quality of life in patients with coronary artery disease (CAD). The study was conducted between February 2022 and May 2024 at the university's Physical Medicine and Rehabilitation Department. Patients were enrolled based on specific inclusion and exclusion criteria, including stable CAD and adequate technological access for TCR participation. The study design all...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age ≥ 18 years.
  • Diagnosis of clinically stable coronary artery disease (CAD), defined as stable angina pectoris, a history of myocardial infarction, history of percutaneous coronary intervention, or coronary artery bypass graft surgery.
  • Classified as having a low to moderate risk of experiencing a new cardiac event, according to established risk stratification guidelines.
  • Possession of a smartphone and reliable internet access at home to facilitate participation in telehealth interventions.
  • Exclusion Criteria:
  • Presence of severe ventricular arrhythmias during low to moderate exercise intensity or a documented history of myocardial ischemia, unstable angina, or abnormal exercise test results during initial evaluation.
  • Presence of a pacemaker or implantable cardioverter-defibrillator that may interfere with study protocols.
  • Hospitalization for any cardiac condition within the last 6 weeks prior to enrollment.
  • Evidence of residual coronary artery stenosis necessitating revascularization procedures.
  • Classification of heart failure as New York Heart Association (NYHA) Class IV, indicating severe functional limitations.
  • Diagnosis of untreated malignancy that could affect participation and outcomes.
  • Presence of orthopedic, neurological, or psychiatric disorders that may hinder assessment or engagement in prescribed exercise regimens.

Trial Officials

Ülkü Nesrin Demirsoy, MD

Principal Investigator

Gazi University Faculty of Medicine

Nihan Burhandağ, MD

Principal Investigator

Gazi University Faculty of Medicine

Levent Karataş, MD

Principal Investigator

Gazi University Faculty of Medicine

About Gazi University

Gazi University, a leading research institution based in Ankara, Turkey, is committed to advancing medical knowledge and improving patient care through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university integrates cutting-edge research with clinical practice to explore new therapeutic approaches and enhance existing treatments. Gazi University adheres to the highest ethical standards and regulatory guidelines, ensuring the integrity and safety of its clinical trials. By fostering partnerships with healthcare professionals and academic institutions, Gazi University aims to contribute significantly to the global scientific community and address pressing health challenges.

Locations

Ankara, , Turkey

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0